Home Contact Sitemap

eRAM

encyclopedia of Rare Disease Annotation for Precision Medicine




Disease sickle cell anemia
Symptom C0030193|pain
Sentences 39
PubMedID- 24769786 Hospitalist management of vaso-occlusive pain crisis in patients with sickle cell disease using a pathway of care.
PubMedID- 21157894 Introduction: pain in children with sickle cell disease (scd) is the leading cause of acute care visits and hospitalizations.
PubMedID- 21708890 Transient receptor potential vanilloid 1 mediates pain in mice with severe sickle cell disease.
PubMedID- 24315252 A biopsychosocial-spiritual model of chronic pain in adults with sickle cell disease.
PubMedID- 20466223 We compared meperidine and tramadol with respect to their effects on the hemodynamics and pain relief in patients with sickle cell disease who were admitted to the emergency department with painful crisis.
PubMedID- 24211787 Recent evidence of neuropathic pain among adults with sickle cell disease (scd) reveals a need for adjuvant analgesic treatments for these patients.
PubMedID- 25916256 Aims: to examine the relationship between pain and satisfaction in patients with sickle cell disease.
PubMedID- 22200862 Background: avascular necrosis (avn) is a common morbidity in children with sickle cell disease (scd) that leads to pain and joint immobility.
PubMedID- 21778705 Lactate dehydrogenase and severity of pain in children with sickle cell disease.
PubMedID- 26412995 Hydroxyurea and zileuton differentially modulate cell proliferation and interleukin-2 secretion by murine spleen cells: possible implication on the immune function and risk of pain crisis in patients with sickle cell disease.
PubMedID- 25842346 The effect of sleep continuity on pain in adults with sickle cell disease.
PubMedID- 22737578 4 dactylitis, often referred to as hand-foot syndrome, is frequently the 1st manifestation of pain in children with sickle cell anemia, occurring in 50% of children by 2 years of age.
PubMedID- 25161492 We therefore sought to describe the different presentationsand patterns of abdominal pain in persons with sickle cell disease.
PubMedID- 25472968 The ash 2014 choosing wisely((r)) recommendations include: (1) do not anticoagulate for more than 3 months in patients experiencing a first venous thromboembolic event in the setting of major, transient risk factors for venous thromboembolism; (2) do not routinely transfuse for chronic anemia or uncomplicated pain crises in patients with sickle cell disease; (3) do not perform baseline or surveillance computed tomography scans in patients with asymptomatic, early-stage chronic lymphocytic leukemia; (4) do not test or treat for heparin-induced thrombocytopenia if the clinical pretest probability of heparin-induced thrombocytopenia is low; and (5) do not treat patients with immune thrombocytopenia unless they are bleeding or have very low platelet counts.
PubMedID- 22287873 One serious adverse event, hospitalization for vaso-occlusive pain, occurred in a patient with sickle cell disease, also thought to be unrelated to the drug.
PubMedID- 23055784 sickle cell disease can be associated with frequent, debilitating pain crises requiring hospitalization, and patients may become emotionally dependent on their pediatric provider.
PubMedID- 20464044 Patients with acute pain episode associated with sickle cell disease, headache, backache, renal colic, and trauma (specific isolated injuries) were included.
PubMedID- 21775406 Breathlessness and chest pain in a patient with sickle cell disease.
PubMedID- 25047658 Sleep disturbance, depression and pain in adults with sickle cell disease.
PubMedID- 21910605 We suggest there are clear differences between the reports of pain in patients with sickle cell disease taking short-acting narcotics for pain management as compared to those who are not, a pattern that does not distinguish patients who are managed with long-acting preparations.
PubMedID- 25696917 The ash 2014 choosing wisely(r) recommendations include: (1) do not anticoagulate for more than 3 months in patients experiencing a first venous thromboembolic event in the setting of major, transient risk factors for venous thromboembolism; (2) do not routinely transfuse for chronic anemia or uncomplicated pain crises in patients with sickle cell disease; (3) do not perform baseline or surveillance computed tomography scans in patients with asymptomatic, early-stage chronic lymphocytic leukemia; (4) do not test or treat for heparin-induced thrombocytopenia if the clinical pretest probability of heparin-induced thrombocytopenia is low; and (5) do not treat patients with immune thrombocytopenia unless they are bleeding or have very low platelet counts.
PubMedID- 25764071 Fluid replacement therapy for acute episodes of pain in people with sickle cell disease.
PubMedID- 23799317 The differential diagnosis of chest pain in a patient with sickle cell disease is difficult and may encompass several serious conditions, including chest syndrome, pulmonary embolism and infectious complications.
PubMedID- 24167104 Neuropathic pain in patients with sickle cell disease.
PubMedID- 26291276 Perspective: altered connectivity patterns associated with high pain experience in patients with sickle cell disease suggest a possible role of central mechanisms in sickle cell pain.
PubMedID- 20656451 A review of the literature on the multiple dimensions of chronic pain in adults with sickle cell disease.
PubMedID- 21490765 Research is needed to determine if there is an association between acetaminophen use in early life for the management of pain in children with sickle cell disease and the increased prevalence of asthma or airway hyperreactivity.
PubMedID- 22518081 The peak of pain due to sickle cell disease is achieved by cold period, that of asthma, in the final phase of nocturnal rest and that of hypertension reaches its maximum at the end of the night resting phase.
PubMedID- 23776145 Clinically meaningful measurement of pain in children with sickle cell disease.
PubMedID- 21527519 Hospitalization for pain in patients with sickle cell disease treated with sildenafil for elevated trv and low exercise capacity.
PubMedID- 21661104 Frequently asked questions by hospitalists managing pain in adults with sickle cell disease.
PubMedID- 24247814 Abdominal pain in children with sickle cell disease.
PubMedID- 24889181 Nonsteroidal anti-inflammatory drugs (nsaids) used to treat pain in patients with sickle cell disease (scd) are metabolized by the cyp2c9 enzyme.
PubMedID- 22696351 Fluid replacement therapy for acute episodes of pain in people with sickle cell disease.
PubMedID- 24574587 The therapeutic role of vitamin d in chronic pain associated with sickle cell disease (scd) is well-established.
PubMedID- 20854646 Morphine is commonly used to control moderate and severe pain associated with sickle cell disease.
PubMedID- 25439119 Perceived injustice predicts stress and pain in adults with sickle cell disease.
PubMedID- 23151972 Mental health disorders influence admission rates for pain in children with sickle cell disease.
PubMedID- 22171826 The clinical management of severe pain associated with sickle cell disease (scd) remains challenging.

Page: 1